| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |